In the US, Tazicef (ceftazidime systemic) is a member of the drug class third generation cephalosporins and is used to treat Bacteremia, Bladder Infection, Bone infection, Endocarditis, Endometritis, Febrile Neutropenia, Intraabdominal Infection, Joint Infection, Kidney Infections, Melioidosis, Meningitis, Nosocomial Pneumonia, Otitis Externa, Otitis Media, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Pneumonia with Cystic Fibrosis, Sepsis, Septicemia, Sinusitis, Skin and Structure Infection, Skin Infection and Urinary Tract Infection.
US matches:
- Tazicef
Ingredient matches for Tazicef
Ceftazidime
Ceftazidime is reported as an ingredient of Tazicef in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment